Phase 3 study of K-828-SP (Long-term study of sodium valproate in child patients with spinal muscular atrophy)

Trial Profile

Phase 3 study of K-828-SP (Long-term study of sodium valproate in child patients with spinal muscular atrophy)

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Sep 2017

At a glance

  • Drugs Sodium valproate (Primary)
  • Indications Spinal muscular atrophy
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Kowa Pharmaceutical
  • Most Recent Events

    • 27 Sep 2017 Planned End Date changed from 31 Mar 2018 to 30 Sep 2018.
    • 27 Sep 2017 Status changed from recruiting to active, no longer recruiting.
    • 07 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top